Build Your Comparison

Side-by-side financial analysis
SNAX logo
SNAX
HIMS logo
HIMS
NXRT logo
NXRT
IRT logo
IRT
TDOC logo
TDOC
Try popular comparisons:

Stock Comparison

SNAX vs HIMS vs NXRT vs IRT vs TDOC

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
SNAX
Stryve Foods, Inc.

Packaged Foods

Consumer DefensiveNASDAQ • US
Market Cap$144K
5Y Perf.-100.0%
HIMS
Hims & Hers Health, Inc.

Medical - Equipment & Services

HealthcareNYSE • US
Market Cap$6.62B
5Y Perf.+157.1%
NXRT
NexPoint Residential Trust, Inc.

REIT - Residential

Real EstateNYSE • US
Market Cap$696M
5Y Perf.-17.8%
IRT
Independence Realty Trust, Inc.

REIT - Residential

Real EstateNYSE • US
Market Cap$3.91B
5Y Perf.+41.3%
TDOC
Teladoc Health, Inc.

Medical - Healthcare Information Services

HealthcareNYSE • US
Market Cap$1.35B
5Y Perf.-96.0%

SNAX vs HIMS vs NXRT vs IRT vs TDOC — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
SNAX logoSNAX
HIMS logoHIMS
NXRT logoNXRT
IRT logoIRT
TDOC logoTDOC
IndustryPackaged FoodsMedical - Equipment & ServicesREIT - ResidentialREIT - ResidentialMedical - Healthcare Information Services
Market Cap$144K$6.62B$696M$3.91B$1.35B
Revenue (TTM)$19M$2.37B$252M$662M$2.51B
Net Income (TTM)$-15M$-13M$-32M$48M$-171M
Gross Margin10.5%67.6%91.1%20.2%65.6%
Operating Margin-60.4%1.3%11.5%17.5%-7.6%
Forward P/E59.2x113.5x
Total Debt$24M$1.26B$1.56B$2.28B$1.04B
Cash & Equiv.$369K$229M$14M$48M$781M

SNAX vs HIMS vs NXRT vs IRT vs TDOCLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

SNAX
HIMS
NXRT
IRT
TDOC
StockJun 20Jun 26Return
Stryve Foods, Inc. (SNAX)1000.0-100.0%
Hims & Hers Health,… (HIMS)100257.1+157.1%
NexPoint Residentia… (NXRT)10082.2-17.8%
Independence Realty… (IRT)100141.3+41.3%
Teladoc Health, Inc. (TDOC)1004.0-96.0%

Price return only. Dividends and distributions are not included.

Quick Verdict: SNAX vs HIMS vs NXRT vs IRT vs TDOC

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: IRT leads in 3 of 7 categories (5-stock set), making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. Hims & Hers Health, Inc. is the stronger pick specifically for growth and revenue expansion and valuation and capital efficiency. NXRT and TDOC also each lead in at least one category. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
🥇IRT emerged as the overall leader. Track its performance:
SNAX
Stryve Foods, Inc.
The Lower-Volatility Pick

Among these 5 stocks, SNAX doesn't own a clear edge in any measured category.

Best for: consumer defensive exposure
HIMS
Hims & Hers Health, Inc.
The Growth Play

HIMS is the #2 pick in this set and the best alternative if growth exposure and long-term compounding is your priority.

  • Rev growth 59.0%, EPS growth -3.8%, 3Y rev CAGR 64.5%
  • 207.9% 10Y total return vs IRT's 202.4%
  • 59.0% revenue growth vs SNAX's -40.9%
  • Lower P/E (59.2x vs 113.5x)
Best for: growth exposure and long-term compounding
NXRT
NexPoint Residential Trust, Inc.
The Real Estate Income Play

NXRT ranks third and is worth considering specifically for income & stability and defensive.

  • Dividend streak 11 yrs, beta 0.53, yield 7.7%
  • Beta 0.53, yield 7.7%, current ratio 0.48x
  • 7.7% yield, 11-year raise streak, vs IRT's 4.0%, (3 stocks pay no dividend)
Best for: income & stability and defensive
IRT
Independence Realty Trust, Inc.
The Real Estate Income Play

IRT carries the broadest edge in this set and is the clearest fit for sleep-well-at-night.

  • Lower volatility, beta 0.30, Low D/E 63.6%, current ratio 0.05x
  • 7.3% margin vs SNAX's -79.1%
  • Beta 0.30 vs HIMS's 2.48, lower leverage
  • 0.8% ROA vs SNAX's -47.8%, ROIC 1.6% vs -39.0%
Best for: sleep-well-at-night
TDOC
Teladoc Health, Inc.
The Momentum Pick

TDOC is the clearest fit if your priority is momentum.

  • +6.3% vs SNAX's -87.3%
Best for: momentum
See the full category breakdown
CategoryWinnerWhy
GrowthHIMS logoHIMS59.0% revenue growth vs SNAX's -40.9%
ValueHIMS logoHIMSLower P/E (59.2x vs 113.5x)
Quality / MarginsIRT logoIRT7.3% margin vs SNAX's -79.1%
Stability / SafetyIRT logoIRTBeta 0.30 vs HIMS's 2.48, lower leverage
DividendsNXRT logoNXRT7.7% yield, 11-year raise streak, vs IRT's 4.0%, (3 stocks pay no dividend)
Momentum (1Y)TDOC logoTDOC+6.3% vs SNAX's -87.3%
Efficiency (ROA)IRT logoIRT0.8% ROA vs SNAX's -47.8%, ROIC 1.6% vs -39.0%

SNAX vs HIMS vs NXRT vs IRT vs TDOC — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

Discover the GLP-1 Stocks Theme

These companies are key players in the GLP-1 Stocks ecosystem. See how they stack up against the rest of the sector.

Explore Theme
SNAXStryve Foods, Inc.
FY 2021
Wholesale
45.4%$14M
e-Commerce
36.1%$11M
Private Label
18.5%$6M
HIMSHims & Hers Health, Inc.

Segment breakdown not available.

NXRTNexPoint Residential Trust, Inc.

Segment breakdown not available.

IRTIndependence Realty Trust, Inc.
FY 2018
Real Estate Other
67.6%$14M
Tenant Reimbursement Income
32.4%$7M
TDOCTeladoc Health, Inc.
FY 2025
Other
100.0%$438M

SNAX vs HIMS vs NXRT vs IRT vs TDOC — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLHIMSLAGGINGTDOC

Income & Cash Flow (Last 12 Months)

Evenly matched — SNAX and NXRT and IRT each lead in 2 of 6 comparable metrics.

TDOC is the larger business by revenue, generating $2.5B annually — 129.9x SNAX's $19M. IRT is the more profitable business, keeping 7.3% of every revenue dollar as net income compared to SNAX's -79.1%. On growth, SNAX holds the edge at +36.4% YoY revenue growth, suggesting stronger near-term business momentum.

MetricSNAX logoSNAXStryve Foods, Inc.HIMS logoHIMSHims & Hers Healt…NXRT logoNXRTNexPoint Resident…IRT logoIRTIndependence Real…TDOC logoTDOCTeladoc Health, I…
RevenueTrailing 12 months$19M$2.4B$252M$662M$2.5B
EBITDAEarnings before interest/tax-$9M$99M$125M$365M$42M
Net IncomeAfter-tax profit-$15M-$13M-$32M$48M-$171M
Free Cash FlowCash after capex-$6M$76M$79M$139M$251M
Gross MarginGross profit ÷ Revenue+10.5%+67.6%+91.1%+20.2%+65.6%
Operating MarginEBIT ÷ Revenue-60.4%+1.3%+11.5%+17.5%-7.6%
Net MarginNet income ÷ Revenue-79.1%-0.6%-12.7%+7.3%-6.8%
FCF MarginFCF ÷ Revenue-32.2%+3.2%+31.2%+21.1%+10.0%
Rev. Growth (YoY)Latest quarter vs prior year+36.4%+3.8%+0.5%+2.5%-2.5%
EPS Growth (YoY)Latest quarter vs prior year+55.6%-3.0%0.0%-101.4%+32.1%
Evenly matched — SNAX and NXRT and IRT each lead in 2 of 6 comparable metrics.

Valuation Metrics

Evenly matched — SNAX and TDOC each lead in 2 of 5 comparable metrics.

At 59.2x trailing earnings, HIMS trades at a 14% valuation discount to IRT's 69.1x P/E. On an enterprise value basis, TDOC's 16.0x EV/EBITDA is more attractive than HIMS's 47.8x.

MetricSNAX logoSNAXStryve Foods, Inc.HIMS logoHIMSHims & Hers Healt…NXRT logoNXRTNexPoint Resident…IRT logoIRTIndependence Real…TDOC logoTDOCTeladoc Health, I…
Market CapShares × price$143,748$6.6B$696M$3.9B$1.3B
Enterprise ValueMkt cap + debt − cash$24M$7.7B$2.2B$6.1B$1.6B
Trailing P/EPrice ÷ TTM EPS-0.00x59.16x-21.76x69.13x-6.54x
Forward P/EPrice ÷ next-FY EPS est.113.47x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple47.84x18.11x16.86x16.02x
Price / SalesMarket cap ÷ Revenue0.01x2.82x2.77x5.94x0.53x
Price / BookPrice ÷ Book value/share0.05x14.40x2.32x1.08x0.95x
Price / FCFMarket cap ÷ FCF89.56x8.32x26.68x4.72x
Evenly matched — SNAX and TDOC each lead in 2 of 5 comparable metrics.

Profitability & Efficiency

IRT leads this category, winning 5 of 9 comparable metrics.

IRT delivers a 1.3% return on equity — every $100 of shareholder capital generates $1 in annual profit, vs $-2 for SNAX. IRT carries lower financial leverage with a 0.64x debt-to-equity ratio, signaling a more conservative balance sheet compared to SNAX's 15.06x. On the Piotroski fundamental quality scale (0–9), IRT scores 6/9 vs SNAX's 3/9, reflecting solid financial health.

MetricSNAX logoSNAXStryve Foods, Inc.HIMS logoHIMSHims & Hers Healt…NXRT logoNXRTNexPoint Resident…IRT logoIRTIndependence Real…TDOC logoTDOCTeladoc Health, I…
ROE (TTM)Return on equity-2.1%-2.5%-10.1%+1.3%-12.4%
ROA (TTM)Return on assets-47.8%-0.6%-1.7%+0.8%-5.9%
ROICReturn on invested capital-39.0%+8.6%+1.1%+1.6%-11.5%
ROCEReturn on capital employed-62.4%+9.4%+1.5%+2.4%-10.0%
Piotroski ScoreFundamental quality 0–934466
Debt / EquityFinancial leverage15.06x2.34x5.18x0.64x0.75x
Net DebtTotal debt minus cash$24M$1.0B$1.5B$2.2B$259M
Cash & Equiv.Liquid assets$369,114$229M$14M$48M$781M
Total DebtShort + long-term debt$24M$1.3B$1.6B$2.3B$1.0B
Interest CoverageEBIT ÷ Interest expense-3.69x0.47x1.73x-8.76x
IRT leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

HIMS leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in HIMS five years ago would be worth $24,996 today (with dividends reinvested), compared to $2 for SNAX. Over the past 12 months, TDOC leads with a +6.3% total return vs SNAX's -87.3%. The 3-year compound annual growth rate (CAGR) favors HIMS at 50.8% vs SNAX's -85.1% — a key indicator of consistent wealth creation.

MetricSNAX logoSNAXStryve Foods, Inc.HIMS logoHIMSHims & Hers Healt…NXRT logoNXRTNexPoint Resident…IRT logoIRTIndependence Real…TDOC logoTDOCTeladoc Health, I…
YTD ReturnYear-to-date+1000.0%-9.7%-3.7%-4.8%+5.8%
1-Year ReturnPast 12 months-87.3%-49.5%-9.7%-3.9%+6.3%
3-Year ReturnCumulative with dividends-99.7%+242.8%-27.4%-0.4%-70.4%
5-Year ReturnCumulative with dividends-100.0%+150.0%-35.4%+6.1%-95.1%
10-Year ReturnCumulative with dividends-100.0%+207.9%+170.0%+202.4%-42.8%
CAGR (3Y)Annualised 3-year return-85.1%+50.8%-10.1%-0.1%-33.4%
HIMS leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — SNAX and IRT each lead in 1 of 2 comparable metrics.

SNAX is the less volatile stock with a -3.16 beta — it tends to amplify market swings less than HIMS's 2.48 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. IRT currently trades 90.8% from its 52-week high vs SNAX's 8.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricSNAX logoSNAXStryve Foods, Inc.HIMS logoHIMSHims & Hers Healt…NXRT logoNXRTNexPoint Resident…IRT logoIRTIndependence Real…TDOC logoTDOCTeladoc Health, I…
Beta (5Y)Sensitivity to S&P 500-3.16x2.48x0.53x0.30x1.85x
52-Week HighHighest price in past year$0.39$70.43$35.08$18.27$9.77
52-Week LowLowest price in past year$0.00$13.74$23.79$14.60$4.40
% of 52W HighCurrent price vs 52-week peak+8.5%+42.8%+78.2%+90.8%+76.4%
RSI (14)Momentum oscillator 0–10066.451.550.159.659.0
Avg Volume (50D)Average daily shares traded58424.7M160K2.2M4.4M
Evenly matched — SNAX and IRT each lead in 1 of 2 comparable metrics.

Analyst Outlook

NXRT leads this category, winning 2 of 2 comparable metrics.

Analyst consensus: HIMS as "Hold", NXRT as "Hold", IRT as "Buy", TDOC as "Hold". Consensus price targets imply 17.5% upside for IRT (target: $20) vs -10.5% for HIMS (target: $27). For income investors, NXRT offers the higher dividend yield at 7.69% vs IRT's 3.96%.

MetricSNAX logoSNAXStryve Foods, Inc.HIMS logoHIMSHims & Hers Healt…NXRT logoNXRTNexPoint Resident…IRT logoIRTIndependence Real…TDOC logoTDOCTeladoc Health, I…
Analyst RatingConsensus buy/hold/sellHoldHoldBuyHold
Price TargetConsensus 12-month target$27.00$27.00$19.50$7.40
# AnalystsCovering analysts20102742
Dividend YieldAnnual dividend ÷ price+7.7%+4.0%
Dividend StreakConsecutive years of raises0114
Dividend / ShareAnnual DPS$2.11$0.66
Buyback YieldShare repurchases ÷ mkt cap0.0%+1.4%+1.1%+0.8%0.0%
NXRT leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

IRT leads in 1 of 6 categories (Profitability & Efficiency). HIMS leads in 1 (Total Returns). 3 tied.

Best OverallHims & Hers Health, Inc. (HIMS)Leads 1 of 6 categories
Loading custom metrics...

SNAX vs HIMS vs NXRT vs IRT vs TDOC: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is SNAX or HIMS or NXRT or IRT or TDOC a better buy right now?

For growth investors, Hims & Hers Health, Inc.

(HIMS) is the stronger pick with 59. 0% revenue growth year-over-year, versus -40. 9% for Stryve Foods, Inc. (SNAX). Hims & Hers Health, Inc. (HIMS) offers the better valuation at 59. 2x trailing P/E, making it the more compelling value choice. Analysts rate Independence Realty Trust, Inc. (IRT) a "Buy" — based on 27 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — SNAX or HIMS or NXRT or IRT or TDOC?

On trailing P/E, Hims & Hers Health, Inc.

(HIMS) is the cheapest at 59. 2x versus Independence Realty Trust, Inc. at 69. 1x.

03

Which is the better long-term investment — SNAX or HIMS or NXRT or IRT or TDOC?

Over the past 5 years, Hims & Hers Health, Inc.

(HIMS) delivered a total return of +150. 0%, compared to -100. 0% for Stryve Foods, Inc. (SNAX). Over 10 years, the gap is even starker: HIMS returned +207. 9% versus SNAX's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — SNAX or HIMS or NXRT or IRT or TDOC?

By beta (market sensitivity over 5 years), Stryve Foods, Inc.

(SNAX) is the lower-risk stock at -3. 16β versus Hims & Hers Health, Inc. 's 2. 48β — meaning HIMS is approximately -179% more volatile than SNAX relative to the S&P 500. On balance sheet safety, Independence Realty Trust, Inc. (IRT) carries a lower debt/equity ratio of 64% versus 15% for Stryve Foods, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — SNAX or HIMS or NXRT or IRT or TDOC?

By revenue growth (latest reported year), Hims & Hers Health, Inc.

(HIMS) is pulling ahead at 59. 0% versus -40. 9% for Stryve Foods, Inc. (SNAX). On earnings-per-share growth, the picture is similar: Teladoc Health, Inc. grew EPS 80. 6% year-over-year, compared to -30. 8% for NexPoint Residential Trust, Inc.. Over a 3-year CAGR, HIMS leads at 64. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — SNAX or HIMS or NXRT or IRT or TDOC?

Independence Realty Trust, Inc.

(IRT) is the more profitable company, earning 8. 6% net margin versus -107. 5% for Stryve Foods, Inc. — meaning it keeps 8. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: IRT leads at 18. 4% versus -87. 1% for SNAX. At the gross margin level — before operating expenses — NXRT leads at 84. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is SNAX or HIMS or NXRT or IRT or TDOC more undervalued right now?

Analyst consensus price targets imply the most upside for IRT: 17.

5% to $19. 50.

08

Which pays a better dividend — SNAX or HIMS or NXRT or IRT or TDOC?

In this comparison, NXRT (7.

7% yield), IRT (4. 0% yield) pay a dividend. SNAX, HIMS, TDOC do not pay a meaningful dividend and should not be held primarily for income.

09

Is SNAX or HIMS or NXRT or IRT or TDOC better for a retirement portfolio?

For long-horizon retirement investors, Stryve Foods, Inc.

(SNAX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -3. 16)). Teladoc Health, Inc. (TDOC) carries a higher beta of 1. 85 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SNAX: -100. 0%, TDOC: -42. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between SNAX and HIMS and NXRT and IRT and TDOC?

These companies operate in different sectors (SNAX (Consumer Defensive) and HIMS (Healthcare) and NXRT (Real Estate) and IRT (Real Estate) and TDOC (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: SNAX is a small-cap quality compounder stock; HIMS is a small-cap high-growth stock; NXRT is a small-cap income-oriented stock; IRT is a small-cap income-oriented stock; TDOC is a small-cap quality compounder stock. NXRT, IRT pay a dividend while SNAX, HIMS, TDOC do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.